← Toutes les actions

ASML vs AVGO

ASML Holding N.V. New York Registry Shares vs Broadcom Inc. Common Stock. Scores ACCE, valorisation, rentabilité et croissance côte à côte.

Scores ACCE
ASML
AVGO
Score composite
Sur 100
74
71
Croissance
80
100
Valeur
24
32
Qualité
96
91
Momentum
97
61
Valorisation
ASML
AVGO
Cours
1 711,32
362,66
Capitalisation
645,26 Md
1,73 Bn
PER glissant
57,81
46,32
PER prévisionnel
27,86
19,05
VE / EBITDA
46,79
33,29
Rendement du dividende
0,5 %
0,7 %
Rentabilité
ASML
AVGO
ROE
53,9 %
44,3 %
Marge nette
30,1 %
42,9 %
Dette / capitaux propres
0,22
0,80
Flux de trésorerie disponible
10,65 Md
26,91 Md
Croissance
ASML
AVGO
Croissance du chiffre d'affaires (sur 1 an)
21,3 %
85,5 %
Croissance des bénéfices (sur 1 an)
28,5 %
2,2 %
Objectif des analystes
2 137,63
531,85
Verdict ACCE

$AVGO edges out $ASML — but neither is cheap

$AVGO wins this matchup on growth and valuation trajectory. Its revenue surged 47.9% YoY and earnings exploded 85.4% YoY, earning a perfect Growth score of 100/100. More importantly, its forward P/E of 19.8x is dramatically lower than its trailing P/E of 59.9x, signaling rapid earnings normalization ahead. Analysts see 45.3% upside to a $523.73 target from the current $360.45.

$ASML is the higher-quality business on paper — ROE of 52.2% versus $AVGO's 37.3%, and a near-perfect Quality score of 96/100. Its Momentum score of 97/100 and a stunning +122.7% 1Y return reflect genuine market enthusiasm. But at a forward P/E of 48.5x on just 13.2% revenue growth, the valuation demands perfection. The 6-model fair value of $671.51 implies 62% downside from $1,769.32 — a sobering gap.

$AVGO's own 6-model fair value of $232.70 flags overvaluation too, but its 38.9% net margin and collapsing forward multiple make the risk/reward more defensible. $ASML's premium is harder to justify at current growth rates.

Voir l'analyse complète